Jim Simons Vyant Bio, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.52 - $0.89 $260 - $445	500 Added 2.46%	20,800 $12,000
Q2 2022 Aug 12, 2022	BUY	$0.62 - $1.37 $551 - $1,219	890 Added 4.59%	20,300 $18,000
Q1 2022 May 13, 2022	SELL	$0.99 - $1.61 $76,162 - $123,860	-76,932 Reduced 79.85%	19,410 $28,000
Q4 2021 Feb 11, 2022	SELL	$1.32 - $2.96 $16,972 - $38,059	-12,858 Reduced 11.77%	96,342 $130,000
Q3 2021 Nov 12, 2021	BUY	$2.26 - $3.74 $246,791 - $408,408	109,200 New	109,200 $254,000
Q2 2021 Aug 13, 2021	SELL	$2.88 - $4.81 $521,066 - $870,254	-180,926 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.89 - $8.6 $522,876 - $1.56 Million	180,926 New	180,926 $839,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.